Physician profile
Robert J Cornell
NPI 1457331803
$7,811.87
in general payments reported to CMS, 2019-2025
23 companies · $536 in 2025
The $536 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,531 · 2020: $1,150 · 2021: $1,602 · 2022: $951 · 2023: $1,125 · 2024: $918 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,578.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,355.60 | 2019-2025 | Ams 700, Ams 700 Cxr Rte Kit, General - Erectile Dysfunction |
| Coloplast Corp | $1,964.88 | 2019-2025 | Titan |
| Astellas Pharma US INC | $942.06 | 2019-2024 | Xtandi, Myrbetriq |
| Pfizer INC. | $845.55 | 2019-2024 | |
| Axonics, INC. | $668.11 | 2020-2021 | |
| Endo Pharmaceuticals INC. | $232.16 | 2019-2021 | |
| Antares Pharma, INC. | $167.78 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Medtronic, INC. | $141.92 | 2021-2024 | Interstim |
| Convatec INC. | $88.46 | 2019 | |
| Ferring Pharmaceuticals INC. | $63.60 | 2019 | |
| Olympus America INC. | $57.26 | 2019-2022 | |
| Acerus Pharmaceuticals Corporation | $50.54 | 2020-2021 | |
| Halozyme INC | $36.49 | 2023 | |
| Wound Management Technologies, INC | $35.67 | 2019 | |
| Innovation Technologies INC | $33.12 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $26.50 | 2019 | |
| Travere Therapeutics, INC. | $20.11 | 2019 | |
| Abbvie INC. | $19.52 | 2019 | |
| 180 Medical, INC. | $18.83 | 2019 | |
| Reflow Medical INC | $16.46 | 2024 | |
| Duchesnay USA Incorporated | $15.69 | 2019 | |
| Mission Pharmacal Company | $11.56 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cornell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.